RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @CarlosdelRio7: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | The Recovery dexamethasone study is now publ…
RT @docramiro: Reducción de mortalidad en Pacientes hospitalizados con #COVID19 que reciben oxígeno o que tienen ventilación mecánica usand…
RT @DrNeilStone: We've had the press release.We've had the https://t.co/KFbunVl08n we have the paper in @nejm. #Dexamethasone for hospita…
新薬やワクチン云々でなく 既存薬の有効活用で 治療はなんとかなりそうな気もする。 無論、100%はないんで完全と言えないが。
RT @wszczeklik: WYNIKI badania RECOVERY ukazały się dzisiaj w NEJM! 6mg deksametazonu przez 10 dni powinni dostawać wszyscy pacjenci z #COV…
RT @kamleshkhunti: RECOVERY Trial published - use of dexamethasone resulted in lower 28-day mortality in those receiving invasive mechanic…
RT @nbennett04: Recovery trial using dexamethasone https://t.co/XDiZbXOgJM https://t.co/qiCkiPcnzy
Recovery trial using dexamethasone https://t.co/XDiZbXOgJM https://t.co/qiCkiPcnzy
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @FranciscoMarty_: #Dexamethasone in Hospitalized Patients with #Covid19 https://t.co/LTzlFEw48f #RecoveryTrial out after peer review…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @NIHRresearch: Results for #dexamethasone from the NIHR funded & supported #RECOVERYtrial have now been published in The New England Jou…
RT @docramiro: Reducción de mortalidad en Pacientes hospitalizados con #COVID19 que reciben oxígeno o que tienen ventilación mecánica usand…
🔴 دگزامتازون در کوید۱۹، مرگ ومیر بیماران تحت ونتیلاتور را تا 36% کاهش داده است و مرگ ومیر بیماران نیازمند اکسیژن (بدون ونتیلاسیون) را تا 18% کم کرده است ولی در کاهش مرگ و میر در بیمارانی که نیاز به حمایت اکسیژن نداشته اند موثر نبوده است. #اعدام_نکنید ht
RT @FranciscoMarty_: #Dexamethasone in Hospitalized Patients with #Covid19 https://t.co/LTzlFEw48f #RecoveryTrial out after peer review…
RT @DrNeilStone: We've had the press release.We've had the https://t.co/KFbunVl08n we have the paper in @nejm. #Dexamethasone for hospita…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RECOVERY Trial published - use of dexamethasone resulted in lower 28-day mortality in those receiving invasive mechanical ventilation or oxygen alone https://t.co/rBkCOLBTiU Great trial @MartinLandray & team 👏👏👏 https://t.co/74i1ne9A4o
RT @wszczeklik: WYNIKI badania RECOVERY ukazały się dzisiaj w NEJM! 6mg deksametazonu przez 10 dni powinni dostawać wszyscy pacjenci z #COV…
RECOVERY trial NEJM out today. Seems similar to pre-print. Comments from the squad? @paulsaundersMD @robertpdickson @NidaQadirMD @ColinRCooke @toddrice_ICU @LekshmiMD @gsmartinmd @BobLeeMD https://t.co/BOlYQA3S28
#Dexamethasone in Hospitalized Patients with #Covid-19 — Preliminary Report | @NEJM https://t.co/QbEySOcO6o
RT @FranciscoMarty_: #Dexamethasone in Hospitalized Patients with #Covid19 https://t.co/LTzlFEw48f #RecoveryTrial out after peer review…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @CarlosdelRio7: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | The Recovery dexamethasone study is now publ…
At last in paper! Even though in Tamilnadu we have being giving low dose MetPred in pulse form
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
Al fin publicado: DXMT 6 mg/día menor mortalidad en NAC COVID con req oxígeno, mayor impacto en pctes en VMI. 1 día menos de hospitalización. Pendiente saber sobre RAM (hiperglicemia, delirium) @SochinfOficial @sochimioficial @colmedchile @SerChile https:
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report | NEJM https://t.co/Jdu6JPvc0Q
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @FranciscoMarty_: #Dexamethasone in Hospitalized Patients with #Covid19 https://t.co/LTzlFEw48f #RecoveryTrial out after peer review…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
Results for #dexamethasone from the NIHR funded & supported #RECOVERYtrial have now been published in The New England Journal of Medicine. The cheap & widely available steroid is the first proven drug to improve survival in COVID19 https://t.co/xg3
Now, nobody can say that there is no treatment in COVID-19. This along with Remdesivir can likely make a difference. Thanks for sharing
デキサメサゾン投与にて約11%死亡率が減少→軽微 A total of 2104 patients were assigned to receive dexamethasone and 4321 to receive usual care. Overall, 482 patients (22.9%) in the dexamethasone group and 1110 patients (25.7%) in the usual care group died https://t.co/aTO0cMK9x7
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
Recovery Trial is out. Dexmethasone reduces death...#COVID19
RT @PeterHorby: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report now published @NEJM #recoverytrial https://t.co/T…
#RECOVERY trial of dexamethasone is now published in @NEJM. ➡️https://t.co/xMjnDVfkTh Will have to read closely but on first look it seems very similar to the #preprint.
RT @docramiro: Reducción de mortalidad en Pacientes hospitalizados con #COVID19 que reciben oxígeno o que tienen ventilación mecánica usand…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
Dexamethasone beats all the expensive drugs. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | NEJM https://t.co/n7Xx1P71kV
We've had the press release.We've had the https://t.co/KFbunVl08n we have the paper in @nejm. #Dexamethasone for hospitalised patients with #Covid_19 The message remains compelling - there is a significant benefit in giving dex to patients with severe C
RT @PeterHorby: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report now published @NEJM #recoverytrial https://t.co/T…
RT @GermHunterMD: 🔥 #RECOVERYtrial study of dexamethasone in hospitalized patients with Covid19 now peer reviewed and published @NEJM See…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
Article from the recovery trial evaluating dexamethasone for covid-19 published in NEJM. https://t.co/KsUQ73tZ3Q
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
"CONCLUSIONS In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respira
RT @FranciscoMarty_: #Dexamethasone in Hospitalized Patients with #Covid19 https://t.co/LTzlFEw48f #RecoveryTrial out after peer review…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
There's your publication: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report of the RECOVERY trial - in @NEJM - https://t.co/erAH0X1kLv #COVID19
RT @FranciscoMarty_: #Dexamethasone in Hospitalized Patients with #Covid19 https://t.co/LTzlFEw48f #RecoveryTrial out after peer review…
RT @MartinLandray: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | NEJM https://t.co/wKkAmAc91X
RT @doogiehowser03: From @NEJM - Decadron reduced 28 day death rates in #COVIDー19 patients who are on ANY kind of oxygen or ventilation. No…
Finalmente saiu o RECOVERY no New England. Interessante que teve um estudo brasileiro com um desenho parecido (o coalizão), um dos braços com dose alta de dexametasona. Vamos ver se eles conseguem submeter algo a tempo... https://t.co/qbsKgPU2Tf
RT @PeterHorby: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report now published @NEJM #recoverytrial https://t.co/T…
RT @analise_covid19: Ensaio clínico controlado e randomizado da Recovery mostrando que a Dexametasona reduziu a mortalidade em 28 dias em p…
RT @BiotechMania: イギリスで先月概要公表された大規模研究で重症COVID19へのデキサメサゾン(DEX)の効果を示す論文がニューイングランド・ジャーナル・オブ・メディスン誌掲載。人工呼吸装着例の28日時点死亡率がDEX投与群29.3%、対象群41.4%で有意に…
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | NEJM https://t.co/wvFvogjxOg
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @analise_covid19: Ensaio clínico controlado e randomizado da Recovery mostrando que a Dexametasona reduziu a mortalidade em 28 dias em p…
From @NEJM - Decadron reduced 28 day death rates in #COVIDー19 patients who are on ANY kind of oxygen or ventilation. Not in others. https://t.co/7rv8qxUkg1
RT @docramiro: Reducción de mortalidad en Pacientes hospitalizados con #COVID19 que reciben oxígeno o que tienen ventilación mecánica usand…
RT @chngin_the_wrld: Mortality decrease associated w/ #Dexamethasone in Hospitalized Patients with #Covid19 (but only among most severely i…
RT @chngin_the_wrld: Mortality decrease associated w/ #Dexamethasone in Hospitalized Patients with #Covid19 (but only among most severely i…
RT @GermHunterMD: 🔥 #RECOVERYtrial study of dexamethasone in hospitalized patients with Covid19 now peer reviewed and published @NEJM See…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @PeterHorby: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report now published @NEJM #recoverytrial https://t.co/T…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
Mortality decrease associated w/ #Dexamethasone in Hospitalized Patients with #Covid19 (but only among most severely ill patients) @NEJM https://t.co/MQbyBIuDpM
#RECOVERYtrial out in print @NEJM Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report https://t.co/kAq3FWcixF
RT @FranciscoMarty_: #Dexamethasone in Hospitalized Patients with #Covid19 https://t.co/LTzlFEw48f #RecoveryTrial out after peer review…
RT @CarlosdelRio7: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | The Recovery dexamethasone study is now publ…
@MountPccm
RT @PICJournalWatch: #recovery #Dexamethasone in Hospitalized Patients with #Covid19 — Preliminary Report | @NEJM https://t.co/ooe76KoZm7
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
What a four months it has been working on the RECOVERY trial @uclh @UCLHresearch with an amazing team from @HTropDis @UCLInfectImm @LSHTM @SwissTPH @NDMOxford @UCLIoN as part of the national #COVID19 response #therapeutics #dexamethasone #whywedoresearch
RT @docramiro: Reducción de mortalidad en Pacientes hospitalizados con #COVID19 que reciben oxígeno o que tienen ventilación mecánica usand…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | NEJM https://t.co/L41owb47ac
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
#recovery #Dexamethasone in Hospitalized Patients with #Covid19 — Preliminary Report | @NEJM https://t.co/ooe76KoZm7
RT @CarlosdelRio7: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | The Recovery dexamethasone study is now publ…
#covid Treatment with dexamethasone.
RT @BiotechMania: イギリスで先月概要公表された大規模研究で重症COVID19へのデキサメサゾン(DEX)の効果を示す論文がニューイングランド・ジャーナル・オブ・メディスン誌掲載。人工呼吸装着例の28日時点死亡率がDEX投与群29.3%、対象群41.4%で有意に…
RT @analise_covid19: Ensaio clínico controlado e randomizado da Recovery mostrando que a Dexametasona reduziu a mortalidade em 28 dias em p…
RT @HerrmannMd: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report | NEJM Now peer reviewed #COVID19 https://t.co/d…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…
RT @PeterHorby: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report now published @NEJM #recoverytrial https://t.co/T…
RT @FranciscoMarty_: #Dexamethasone in Hospitalized Patients with #Covid19 https://t.co/LTzlFEw48f #RecoveryTrial out after peer review…
RT @EricTopol: The dexamethasone #recoverytrial, showing survival advantage for severe #COVID19, was just published in @NEJM, with an acco…